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Cyclic AMP and its receptor protein negatively regulate the
coordinate expression of cholera toxin and toxin-coregulated
pilus in Vibrio cholerae
(gene regulationyenvironmental stimuliypathogenesis)
KAREN SKORUPSKI* AND RONALD K. TAYLOR
Department of Microbiology, Dartmouth Medical School, Hanover, NH 03755
Communicated by R. J. Collier, Harvard Medical School, Boston, MA, November 14, 1996 (received for review September 13, 1996)
ABSTRACT Insertion mutations in two Vibrio cholerae
genes, cya and crp, which encode adenylate cyclase and the
cyclic AMP (cAMP) receptor protein (CRP), respectively,
derepressed the expression of a chromosomal cholera toxin
(CT) promoter–lacZ fusion at the nonpermissive temperature
of 37&C. In the classical biotype strain O395, the crp mutation
increased the production of both CT and toxin-coregulated
pilus (TCP) in vitro under a variety of growth conditions not
normally permissive for their expression. The most dramatic
increase in CT and TCP was observed with the crp mutant in
Luria–Bertani (LB) medium pH 8.5, at 30&C. El Tor biotype
strains differ from classical strains in that they do not produce
CT or TCP when grown in LB media. Incorporation of the crp
mutation into El Tor strain C6706 permitted production of these
proteins in LB medium pH 6.5, at 30&C. In the infant mouse
cholera model, the crp mutation decreased colonization in both
biotypes at least 100-fold relative to the wild-type strains. The
data presented here suggest a model whereby cAMP–CRP neg-
atively regulates the expression of CT and TCP in both classical
and El Tor biotypes under certain environmental conditions and
also influences pathogenesis by regulating other processes nec-
essary for optimal growth in vivo.
The human pathogen Vibrio cholerae O1 is a Gram-negative
bacterium that colonizes the epithelium of the upper intestine
and causes a severe diarrheal disease by secreting a potent
ADP-ribosylating exotoxin. Cholera toxin (CT) is a multimeric
protein composed of one A subunit and five B subunits
encoded by the ctxAB operon (1). Coordinately expressed with
CT is the toxin-coregulated pilus (TCP) (2), which plays a
major role in the intestinal colonization by the bacterium. The
transmembrane DNA-binding protein ToxR positively regu-
lates the expression of CT, TCP, and accessory colonization
factors (ACF) (3–5). Whereas activation of ctx is thought to
occur by direct binding of ToxR to the promoter (5), ToxR
controls the expression of the TCP and accessory colonization
factor genes indirectly by activating the expression of another
positive regulator, ToxT (6). Since the toxT gene is located
within the TCP gene cluster, transcriptional readthrough from
the tcpA promoter, the most proximal promoter in this operon,
apparently also contributes to its expression (7). Although the
mechanisms are not clearly understood, ToxT also plays a role
in activating ctx expression (6).
The control of virulence gene expression in V. cholerae is
strongly influenced by environmental stimuli. The function of
such regulation may be to conserve resources under conditions
that would not support a productive infection. One marked
difference between the two epidemic biotypes of V. cholerae
O1, classical and El Tor, is the way in which environmental
stimuli exert control over the expression of ToxR-regulated
genes. For example, with classical strains, the expression of ctx,
tcp, and other genes in the ToxR regulon are maximal in
Luria–Bertani (LB) medium pH 6.5, at 308C in NaCl concen-
trations of approximately 66 mM (2, 3, 8). At 378C, pH 8.5, or
in higher or lower osmolarities, expression is reduced. In the
case of El Tor strains, CT and TCP are not produced in LB
media, but they can be induced by growth of the strains in a
bicarbonate medium (AKI) without aeration followed by
incubation with vigorous aeration (9). The mechanisms by
which environmental stimuli exhibit control over the ToxR
regulon in either biotype are presently unclear.
To elucidate the mechanisms by which stimuli from the
environment control the expression of ToxR-regulated viru-
lence genes, we constructed a chromosomal ctx–lacZ fusion in
V. cholerae to screen for mutations in genes that alter this
control. By screening for derepression of the fusion at the
normally nonpermissive temperature of 378C, we identified an
insertion mutation in the V. cholerae cya gene, the structural
gene for adenylate cyclase, which catalyzes the synthesis of
cyclic AMP (cAMP). An insertion mutation in crp, the gene
encoding the cAMP receptor protein (CRP) was subsequently
engineered and was found to similarly derepress the expression
of the ctx–lacZ fusion under certain environmental conditions.
The cAMP–CRP system is a well-known global regulator of
catabolite repression in enteric bacteria (for a review see ref.
10) and has recently received attention for its role in modu-
lating virulence gene expression and pathogenesis in Salmo-
nella typhimurium (11, 12). The results presented here indicate
that in V. cholerae cAMP–CRP influences both the expression
of ToxR-regulated virulence genes and pathogenesis.
MATERIALS AND METHODS
Bacterial Strains and Media. Escherichia coli and V. chol-
erae strains were maintained at 2708C in LB medium (13)
containing 30% (volyvol) glycerol. The V. cholerae strains
constructed in this study were derived from either the classical
strain O395 (2) or its lacD derivative CG842 (14) and the El
Tor strain C6706str2 (15): KSK218 (CG842 ctx–lacZ), KSK369
(KSK218 crp::kan81), KSK377 (O395 crp::kan81), KSK236
(KSK218 toxR55), KSK374 (KSK369 toxR55), and KSK394
(C6706str2 crp::kan81). Antibiotics were used at the following
concentrations in LB medium: ampicillin, 100 mgyml; tetra-
cycline, 15 mgyml; kanamycin (Km), 45 mgyml; chloramphen-
icol, 34 mgyml for E. coli and 6 mgyml for V. cholerae;
streptomycin, 100 mgyml except when selecting for loss of
integrated plasmids in V. cholerae, where it was used at 1
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mgyml. In MacConkey agar (Difco), carbohydrates were used
at 0.4% and antibiotics were used at concentrations 1⁄2 those
listed above. 5-Bromo-4-chloro-3-indolyl b-D-galactoside (X-
Gal) was used in LB agar at 40 mgyml.
Construction of the ctx–lacZ Fusion. The ctx–lacZ operon
fusion was constructed as follows: A 542-bp ctxA fragment and
a 492-bp ctxB fragment were amplified by PCR from V.
cholerae O395 using oligonucleotide primers CTX1a (59-
GACTCGA AT TCGCATGCGCAGTCAGGTG -
GTCTTATG) and CTX1b (59-GACTCGGATCCGAGCAT-
TCCCACAACCCGG) and CTX2a (59-GACTCGGATC-
CTCTAGACCATGGATCAGTAATACTTGCGATG) and
CTX2b (59-GACTCGTCGACCGACTTTAGCTTCAG-
TAAG), respectively. A promoterless E. coli lacZ gene and a
chloramphenicol-resistance gene were inserted between the
two ctx fragments in pKAS33, a derivative of pGP704 (8)
containing the rpsL gene (16). The resulting fusion was
introduced into CG842 by allelic exchange (16) to generate
strain KSK218. Primer CTX1c (59-CAGATTCTAGACCTC-
CTGATG) was used with either LAC-1 (59-GTCATAGCT-
GTTTCCTGTGTG) or CTX2b to confirm the chromosomal
location of the fusion.
TnphoAMutagenesis.Random insertion of TnphoA into the
chromosome of strain KSK218 was as previously described (2,
17) except that instead of screening for a PhoA1 phenotype,
dark blue colonies were identified on X-Gal plates at 378C. To
generate plasmid pKAS44, a 1-kb fragment was amplified from
an internal portion of the phoA gene of TnphoA using primers
ALKP1 (59-GACTCAGATCTGTAATTATGCCGAAGGT-
GCGG) and ALKP2 (59-GACTCGAGCTCCCCGGGTA-
ACTCATCACCATCACTGCG) and was inserted into
pKAS32 (16). Chromosomal capture plasmids were sequenced
from either end of TnphoA using primers TNPHOA-1 (59-
GCCGGGTGCAGTAATATCG) and IS50R-2 (59-GAAGT-
TATCATGAACGTTACC).
Construction of the crp::kan81 Mutation. A 300-bp frag-
ment from the crp gene of O395 was amplified using primers
CR-1 (59-GATAGCGGCCGCTGTGAAGTGGCTGAAAT-
TTC and CR-3 (59-GATAGCGGCCGCAGGTTCTGATC-
CTCCAGCATC). A 19-bp deletion in the resulting fragment
in plasmid pKAS69 was created by inverse PCR using primers
CR-6 (59-GATCGATATCAGGAACGCAAGGTCGC-
CAAC and CR-7 (59-GATCGATATCGCACAGACTCT-
GCTGAATC). A Km-resistance gene was inserted into the
300-bp fragment at this position, and the resulting 1.3-kb
fragment was inserted into pKAS32 to generate pKAS81. This
mutation, designated crp::kan81, was then introduced into V.
cholerae either by allelic exchange (16) or by CP-T1-mediated
transduction (18).
DNA Sequencing. Cycle sequencing was performed using
the Applied Biosystems Prism Dye System (Perkin–Elmer).
b-Galactosidase and CT Assays. Cultures were inoculated
by dispersing colonies from plates into 1.5 ml of LB medium
at an OD600 of approximately 0.5. Fifty-fold dilutions of the
cultures were then made into 4 ml of LB medium and
incubated on a tube roller at the appropriate temperatures.
b-Galactosidase assays (13) were carried out after 12 hr. The
amount of protein in each reaction was determined by using
the BCA (bicinchoninic acid) procedure (Pierce). GM1 gan-
glioside ELISA CT assays were carried out after 18 hr (19).
The amount of protein in each cell pellet was determined as
above. The data are representative results from at least two
independent experiments.
Gel Electrophoresis and Immunoblot Analysis. Cell pellets
from the CT assays were analyzed by SDSy12.5% polyacryl-
amide slab gel electrophoresis (PAGE) as described (2).
Proteins were visualized either by staining with Coomassie
blue or by transferring to nitrocellulose and probing with
anti-TcpA antibody (20) using the ECL (enhanced chemilu-
minescence) detection system (Amersham).
Colonization and LD50 Assays. The infant mouse competi-
tion assays were performed essentially as described (2). Three-
to five-day-old suckling CD-1 mice (Charles River) were
inoculated orally, and the total colony-forming units (cfu) was
obtained from the small intestine of four mice at various times
over a 24-hr period by plating intestinal homogenates on X-Gal
plates with or without Km. For the two-strain experiments, the
competitive index is defined as the difference between the
input and output ratios of the strains. The LD50 values were
determined by oral challenge with various doses of viable
bacteria. Four mice were used per dose and the results were
analyzed after 36 hr. Prior to inoculation, all strains were
grown in LB medium pH 6.5, at 308C.
RESULTS
Isolation of Mutants Derepressed for ctx Expression by
Using a Chromosomal ctx–lacZ Fusion. A transcriptional
fusion between the CT promoter and the E. coli lacZ gene was
constructed in the V. cholerae chromosome to screen for
insertion mutants with altered CT gene expression under
different environmental conditions. The fusion was initially
constructed on a plasmid by inserting a promoterless lacZ gene
and a chloramphenicol-resistance gene between two ctx DNA
fragments, and it was then transferred to the chromosome of
strain CG842 by allelic exchange. The production of b-galac-
tosidase in the resulting strain, KSK218, mirrored that of ctx
expression both on X-Gal plates and in broth with respect to
a variety of environmental conditions (see below), indicating
that the fusion was properly regulated. The correct localization
of the fusion into both genomic copies of ctx (21) was verified
by PCR.
To isolate V. cholerae mutants derepressed for the expres-
sion of ctx at the normally nonpermissive temperature of 378C,
approximately 10,000 TnphoA mutants of KSK218 were
screened on X-Gal plates for colonies that appeared darker
blue than the parent strain at this temperature. The mutations
that produced the darkest blue colors were then backcrossed
into KSK218 to verify that the observed phenotypes were due
to the insertions. To efficiently backcross the TnphoA inser-
tions, we developed a method which we have termed ‘‘chro-
mosomal capture.’’ In this procedure, a plasmid carrying an
internal portion of the phoA gene, pKAS44, was introduced
into each insertion mutant, where it specifically integrated into
the resident transposon. Chromosomal DNAwas isolated from
each integrant, digested with a restriction enzyme that does not
cut within either TnphoA or pKAS44, and ligated to favor the
formation of monomolecular circles. After transformation of
the DNA into S17-1 l pir (22), selection for ampicillin and Km
identified colonies harboring composite plasmids of pKAS44,
TnphoA, and chromosomal sequences flanking the transposon.
To transfer the transposon insertions back into KSK218, the
pKAS44 composite plasmids were ligated into the broad host
range delivery plasmid pLAFR2 (23) and recovered in the
streptomycin-resistant strain MC4100 (24). After selecting for
loss of the pKAS44 portion of the composite plasmids on
streptomycin and tetracycline, they were used to recombine
the insertions into KSK218, using the IncP1 incompatibility
system (25).
Analysis of V. cholerae cya and crpMutants. After confirm-
ing the phenotypes of several of the strongest mutants iden-
tified above, the corresponding pKAS44 composite plasmids
were sequenced to identify the transposon insertion sites. A
data base BLAST search (26) with sequences from one mutant
revealed that the transposon had inserted in a gene with very
high homology to the adenylate cyclase (cya) genes from a
number of different bacteria. Further analysis of this mutant
showed that it indeed had phenotypes strikingly similar to
those observed with strains that cannot synthesize cAMP (11,
27): a small colony size, slow growth rate, and an inability to
ferment a variety of different carbohydrates. Furthermore, the
266 Microbiology: Skorupski and Taylor Proc. Natl. Acad. Sci. USA 94 (1997)
dark blue, small colony phenotype of the mutant on X-Gal
plates was completely restored to wild type by the addition of
5 mM cAMP to the agar. A difficulty in working with the cya
mutant was its propensity to revert to a wild-type phenotype
at high frequency both on plates and in broth. Although we do
not know the reason for this instability, one mechanism of cya
suppression in E. coli is the formation of compensatory
mutations in the crp gene (28). Thus, to avoid the instability
problems of the cya mutant, we constructed a more stable
mutation in the V. cholerae crp gene.
To construct the crpmutant, oligonucleotides designed from
the E. coli crp sequence (29) were used to amplify an approx-
imately 300-bp fragment from V. cholerae O395. Comparison
of the sequence of the 300-bp fragment with that of the
corresponding region of the E. coli gene (from amino acid 100
to 188) revealed 79% identity between the two at the nucle-
otide level and 94% identity at the amino acid level. A 19-bp
deletion was introduced near the center of the 300-bp frag-
ment, a Km-resistance gene was inserted at this position, and
the resulting mutation was transferred into V. cholerae. The crp
mutant strains produced small, slow growing colonies with a
pleiotropic carbohydrate deficiency, phenotypes similar to
those of the cya mutant described above except that they were
stable on all media tested. As with the cyamutant, the KSK218
crp derivative KSK369 appeared dark blue on X-Gal plates at
378C, indicating that ctx expression was similarly derepressed
in this strain. The lighter blue color of the O395 crp mutant
KSK377 on X-Gal plates indicates that the mutation reduced
the expression of its endogenous lacZ gene. Despite the fact
that V. cholerae does not ferment lactose, it is interesting that
its lacZ gene still appears to be regulated by cAMP–CRP.
The crp Mutant Is Derepressed for ctx Expression Under
Nonpermissive Conditions. The expression of the ctx operon
is positively regulated by ToxR (4) and also controlled by
environmental stimuli such as temperature, pH, and osmolar-
ity (8). Fig. 1 compares the effects of temperature, pH, and a
toxR mutation on the production of b-galactosidase in fusion
strain KSK218 and its crp derivative KSK369. For classical
strains, the optimal in vitro condition for the expression of ctx
is LB medium pH 6.5, at 308C. When grown under this
condition, both KSK218 and its crp derivative KSK369 pro-
duced high levels of b-galactosidase. In pH 8.5 at 308C, a
condition not permissive for ctx expression, the production of
b-galactosidase in KSK218 was reduced almost 10-fold relative
to that at pH 6.5. In contrast, the crpmutant KSK369 produced
essentially the same levels of b-galactosidase at both pH 6.5
and pH 8.5. This result indicates that the absence of functional
CRP allows the strain to overcome the normal repression of ctx
expression that occurs at pH 8.5. At 378C, another condition
not permissive for ctx expression, KSK218 produced 7- to
13-fold less b-galactosidase than at the optimal condition.
Although the crp mutant showed a 4- to 5-fold increase in the
production of b-galactosidase relative to KSK218 at 378C, the
strain did not completely overcome repression under this
condition.
The introduction of a toxRmutation in KSK218 by insertion
of plasmid pVM55 (8) into the chromosome resulted in a
20-fold reduction in b-galactosidase production in strain
KSK236 relative to its toxR1 parent in LB: pH 6.5 at 308C, and,
under the nonpermissive conditions, further decreased pro-
duction approximately 2-fold. The crp toxR mutant KSK374
consistently showed a 2-fold increase in b-galactosidase pro-
duction relative to KSK236 under all conditions examined.
This result indicates that maximal derepression of ctx expres-
sion in the crp mutant depends on ToxR, yet suggests that
cAMP–CRP functions independently of it.
Increased Production of CT and TcpA under Nonpermissive
Conditions by the crp Mutant. Since CT and TCP are coor-
dinately regulated, we examined their production in O395 and
its crp derivative KSK377 under growth conditions similar to
those used above. Autoagglutination is a property associated
with expression of TCP in O395 that normally occurs in vitro
at 308C, pH 6.5, but not at pH 8.5 or at 378C (2). Unlike O395,
the crp mutants KSK369 and KSK377 both autoagglutinated
at pH 6.5 and at pH 8.5 when grown at 308C. Fig. 2 shows
cultures of KSK369 and its parent KSK218 grown in LB, pH
8.5 at 308C. The KSK218 culture (Fig. 2A) appears homoge-
neous, whereas in the KSK369 culture (Fig 2B) the cells
aggregate and form a pellet on the bottom of the tube.
SDSyPAGE analysis of total protein from O395 and KSK377
showed that the mutant indeed produced the 20.5-kDa major
pilin protein TcpA at both pH 6.5 and pH 8.5 (Fig. 3, lanes 3
and 5). Similar levels of CT were also produced under both
conditions. As expected, O395 produced TcpA at pH 6.5 but
not at pH 8.5 (Fig. 3, lanes 2 and 4), and it produced 25-fold
less CT at the higher pH. Although the crp mutant produced
approximately twice as much CT as O395 at 378C, neither
FIG. 1. b-Galactosidase production in the ctx–lacZ fusion strains.
Left half: toxR1 strains KSK369 (crp), black bars, and KSK218 (crp1),
grey bars. Right half: toxR strains KSK374 (crp), black bars, and
KSK236 (crp1), grey bars.
FIG. 2. Autoagglutination pattern of KSK218 and its crp derivative
KSK369. Cultures of KSK218 (A) and KSK369 (B) were grown in LB
medium, pH 8.5, at 308C. Autoagglutinated bacteria are shown by the
arrow.
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strain produced TcpA at this temperature (Fig. 3, lanes 6–9).
The pattern of derepression observed for ctx and tcpA with the
crp mutant at pH 8.5, and to a lesser extent at 378C, suggests
that cAMP–CRP negatively regulates their expression under
these conditions.
Production of CT and TcpA by El Tor crp Mutants in LB
Media. Strains of the El Tor biotype require much more
stringent growth conditions in vitro than classical strains to
elicit the production of CT and TCP (9). The observation that
the crp mutation increased the production of CT and TcpA in
O395 under a number of normally nonpermissive growth
conditions suggested to us that the mutation might have a
similar effect in El Tor strains when grown in LB media, a
condition normally repressive for CT and TcpA production in
this biotype. As expected, El Tor strain C6706 did not produce
TcpA detectable by Western blotting when grown in LB
medium at 308C and made less than 10 ng of CT per mg of
protein per ml (Fig. 4, lanes 2 and 3). In contrast, the C6706
crp mutant KSK394 showed a strong TcpA signal when grown
in LB medium, pH 6.5, at 308C and produced approximately
25-fold more CT than its parental strain (Fig. 4, lane 4). The
amount of CT produced by KSK394 was only 4-fold lower than
that observed for O395. KSK394 also appeared to autoagglu-
tinate in LB medium pH 6.5, at 308C, but not to the extent
normally observed with classical biotype strains. These results
indicate that cAMP–CRP plays a role in the repression of CT
and TcpA production in El Tor strains when grown in LB
media. Interestingly, unlike the situation with classical strains,
KSK394 did not produce detectable TcpA or CT at pH 8.5
(Fig. 4, lane 5), suggesting that even in the absence of a
functional cAMP–CRP system, differences still exist in the way
ToxR-regulated genes are controlled between the two bio-
types.
Decreased Colonization of the crp Mutants in Infant Mice.
The effect of the crp mutation on virulence was assessed for
O395 and its crp derivative KSK377 by determining the LD50
values for each strain in the infant mouse cholera model. These
values, 13 106 for O395 and 53 108 for KSK377, indicate that
the crp mutation decreased the virulence of the strain approx-
imately 500-fold.
Since KSK377 is not impaired for the production of either
CT or TCP in vitro, it seemed unlikely that the attenuation of
virulence observed with the crpmutant was due to a deficiency
in the synthesis of factors important for colonization and
virulence. To assess this, the colonization of KSK377 in infant
mice was compared over a 24-hr period with both its O395
parent and a tcpA mutant, CS2-1 (30), that is defective for
colonization (2). The results of these experiments, shown in
Fig. 5, reveal striking differences in the colonization profiles of
the three strains. The tcpA mutant was incapable of establish-
FIG. 3. TcpA and CT production in O395 and its crp derivative
KSK377. Strains were grown in LB medium pH 6.5, at 308C (lanes 2
and 3), pH 8.5, at 308C (lanes 4 and 5), pH 6.5, at 378C (lanes 6 and
7), and pH 8.5, at 378C (lanes 8 and 9). For each strain, approximately
6 mg of total protein was subjected to SDSyPAGE and stained with
Coomassie blue. CS2-1 (tcpA), lane 1; O395, even-numbered lanes;
KSK377, odd-numbered lanes. TcpA is shown by the arrow. The
amount of CT in each culture supernatant is expressed at the bottom
as ngymg of protein per ml.
FIG. 4. TcpA and CT production in C6706 and its crp derivative
KSK394. Strains were grown at 308C in LB medium, pH 6.5 (lanes 1,
2, and 4), or pH 8.5 (lanes 3 and 5). For each strain, approximately 2
mg of total protein was subjected to SDSyPAGE, electroblotted to
nitrocellulose paper, and probed with anti-TCP antiserum (20). O395,
lane 1; C6706, lanes 2 and 3; KSK394, lanes 4 and 5. TcpA is shown
by the arrow. The amount of CT in each culture supernatant is
expressed at the bottom as ngymg of protein per ml.
FIG. 5. Time course of colonization in the infant mouse cholera
model. Twenty infant mice were orally inoculated with a mixture of
strains O395, KSK377 (crp), and CS2-1 (tcpA). At various times over
a 24-hr period, four mice were sacrificed and the total intestinal cfu per
mouse for each strain was determined and averaged. m, O395; F,
KSK377; å, CS2-1.
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ing even a transient infection and was completely cleared from
the intestine by 12 hr after inoculation. In contrast, KSK377
persisted in the intestine but consistently showed lower cfu per
mouse compared with O395. At 12 hr the mutant was reduced
approximately 100-fold relative to the wild type and by 24 hr
it was reduced 1000-fold. When O395 and KSK377 were grown
together in vitro, the mutant was reduced approximately
60-fold relative to the wild type by 12 hr. These results suggest
that the decreased virulence of KSK377 is at least partially due
to a defect in growth. The in vitro competitive index could not
be calculated at late times in the growth curve, however, since
the cfu for the mutant repeatedly decreased to undetectable
levels. The mutant did not exhibit such a decrease when
cultured alone in vitro, and the reasons for this phenomenon
are presently under investigation. Consistent with the above
hypothesis, the doubling time of KSK377 in LB at 378C was
increased approximately 30% relative to that of wild type, a
value similar to that which has been observed with E. coli crp
mutants (27).
The crp mutation also reduced the virulence of El Tor
biotype strains. For C6706 and its crp derivative, KSK394, the
LD50 values were 5 3 106 and .5 3 108, respectively. To
compare the effect of the crp mutation on colonization
between the two biotypes, the competitive indexes of KSK377
and KSK394 were each determined relative to their parents at
12 and 24 hr after inoculation. The competitive index of each
mutant was between 1021 and 1022 at 12 hr and between 1023
and 1024 by 24 hr. The pattern of in vitro growth for the El Tor
crp mutant was similar to that of the classical crp mutant, and
the doubling time of the strain in LB medium at 378C was also
increased approximately 30% relative to wild type. Thus, with
respect to growth and colonization, the behaviors of the
classical and El Tor crp mutant strains are similar.
DISCUSSION
The evidence presented here indicates that both adenylate
cyclase and CRP influence the expression of ToxR-regulated
virulence genes in response to environmental stimuli. Adenyl-
ate cyclase catalyzes the synthesis of cAMP, one of the most
important and ubiquitous intracellular regulatory molecules.
Together with its receptor protein, CRP, this system plays a
central role in cellular metabolism in enteric bacteria by
regulating the utilization of carbon and energy sources in the
environment. In the presence of high intracellular levels of
cAMP, binding of the nucleotide to CRP results in a confor-
mational change in the protein that induces sequence-specific
DNA binding. CRP functions as both a positive and negative
effector of gene expression and influences many different
cellular processes, including cell division and motility (10).
Both cAMP and CRP also appear to have some individual
regulatory roles. The similarities between the phenotypes of
the V. cholerae cya and crp mutants described here and those
of E. coli and S. typhimurium indicate that in V. cholerae the
cAMP–CRP system functions in an analogous manner. How-
ever, one notable exception regards motility. E. coli and S.
typhimurium cya and crpmutants do not synthesize flagella and
are nonmotile (27, 31), whereas by phase-contrast and electron
microscopy V. cholerae cya and crp mutants appear motile and
produce flagella (data to be presented elsewhere). This finding
is in contrast to a previous report that cAMP is indispensable
for V. cholerae motility (32) and suggests that the synthesis of
monotrichous flagella is regulated differently from that of
peritrichous flagella.
A crpmutation in the classical biotype strain O395 and in the
El Tor strain C6706 increased the production of both CT and
TCP under growth conditions that are normally not permissive
for their expression. In LB medium, pH 8.5, at 308C, the O395
crp mutant produced essentially the same amounts of CT and
TcpA as under the more optimal expression conditions. One
interpretation of these results is that cAMP–CRP functions as
a repressor of ctx and tcpA expression in LB medium, pH 8.5,
at 308C. Since repression of ctx was not completely alleviated
in the crp mutant at 378C, this result suggests that factors in
addition to cAMP–CRP are involved in its repression at this
temperature. In El Tor biotype strains, the absence of CRP
permitted CT and TCP to be produced in LB medium, pH 6.5
at 308C. Thus, in these strains cAMP–CRP is also involved in
the repression of ctx and tcpA under certain growth conditions.
The maximal level of CT produced in the C6706 crp mutant
was still only one-third that of the O395 crpmutant and, unlike
the situation with classical strains, no CT or TcpA was ob-
served with the mutant in LB pH 8.5 at 308C. Thus, funda-
mental differences over the control of the ToxR regulon exist
between the two biotypes even in the absence of the cAMP–
CRP system.
A putative consensus binding site for cAMP–CRP that
overlaps the 235 sequence of the tcpA promoter has been
identified in both classical and El Tor biotypes (33, 34).
Although it is not yet known if CRP binds this site, its presence
suggests a model for how cAMP–CRP may repress the ex-
pression of tcpA and ctx under particular growth conditions. If
binding of the cAMP–CRP complex to this site occludes the
235 region of the tcpA promoter, cAMP–CRP could nega-
tively regulate tcpA expression by preventing access of RNA
polymerase. Although the more typical role for cAMP–CRP is
as a positive regulator of transcription, there are a number of
examples where cAMP–CRP negatively regulates gene expres-
sion. For example, in E. coli, binding of cAMP–CRP to the
promoters of the cya and gal genes negatively regulates their
expression by preventing access of RNA polymerase (35, 36).
In S. typhimurium, cAMP–CRP negatively regulates the ex-
pression of the spv virulence operon (12), but the mechanisms
involved in this regulation are not yet clear.
The coordinate effect of the crp mutation on tcpA and ctx
expression could be explained if repression by cAMP–CRP at
the tcpA promoter also influences the expression of the
downstream regulatory gene toxT. ToxT has been shown to
play a role in the activation of ctx (6), and although its
expression is dependent upon ToxR (6), readthrough from the
tcpA promoter contributes to its steady-state levels (7). Thus,
in a crp mutant, derepression of tcpA would be expected to
increase the expression of toxT, which would, in turn, increase
ctx expression.
The above model is supported by a number of experiments
that indicate that the influence of certain environmental
conditions on the ToxR regulon is controlled at the level of
toxT expression. For example, placing the toxT gene under a
constitutive promoter in O395 alleviates the repression of ctx
that occurs in LB medium pH 8.5 at 308C (6) and similarly
permits El Tor biotype strains to overcome the repression of
ctx and tcpA expression that occurs in LB media (37). The
striking similarity between the phenotypes of the crp mutants
described here and those of the strains carrying the toxT
constitutive constructs suggests that in the crp mutants the
normal regulation of toxT expression has been altered. The
model proposed here thus provides a mechanism for how toxT
expression may be controlled by environmental conditions.
The hypothesis that cAMP–CRP functions through ToxT
rather than ToxR is also supported by the finding that in the
crpmutants, derepression of ctx expression is observed even in
the absence of ToxR. Many aspects of this model remain to be
tested. For example, experiments are currently underway to
determine if CRP binds to the site identified in the tcpA
promoter and whether toxT message is increased in the crp
mutants under the normally repressive growth conditions. We
have also not ruled out the possibility that the effect of
cAMP–CRP on the expression of ctx and tcpA is the result of
its influence over some other aspect of cellular physiology.
The involvement of cAMP–CRP in the regulation of CT and
TCP expression in V. cholerae suggests that carbon and energy
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sources in the environment influence virulence gene expres-
sion. High intracellular levels of cAMP are indicative of
growth on poor carbon sources, whereas lower levels are
present in cells grown in more nutrient-rich environments. It
is not yet clear, however, why cAMP–CRP would repress the
ToxR regulon in vitro either in classical strains grown in LB
medium, pH 8.5, at 308C or in El Tor strains when grown in LB
medium, pH 6.5, at 308C. One possibility is that under these
conditions the bacteria metabolize faster and exhaust their
carbon sources more quickly than when grown in the more
nearly optimal conditions for CT and TCP production. The
down-regulation of virulence gene expression when cAMP
levels are high may serve as a mechanism to limit the expres-
sion of virulence determinants in low-nutrient environments
outside of the host and favor their expression in nutrient-rich
environments such as the intestine. Previous in vitro studies
have failed to demonstrate a relationship between cAMP
levels and CT production in V. cholerae by varying the con-
centration of glucose in the growth media (38). It is possible
that the levels of cAMP in these experiments were not
sufficiently high to reduce CT production. Further work will be
needed to elucidate how cAMP–CRP influences the expres-
sion of CT and TCP in V. cholerae.
The cAMP–CRP system regulates the expression of pilus
and toxin genes in other bacteria. For example, in E. coli, Pap
pili and heat-stable enterotoxin are both positively regulated
by cAMP–CRP (39, 40). This mode of regulation would be
expected to increase the expression of various functions to
facilitate survival in low-nutrient environments. At least one
other report exists of a pilus that is negatively regulated by
cAMP–CRP, the I-sex pilus of E. coli (41). It has recently been
shown in V. cholerae that TCP serves as the receptor for the
phage CTXf (42). That cAMP–CRP negatively regulates TCP
expression suggests that the infectivity of the phage is con-
trolled, at least in part, by intracellular levels of cAMP. In E.
coli and S. typhimurium, lysogenization by temperate bacte-
riophages is influenced by intracellular cAMP levels.
The pathogenic potential of an organism is determined by
many factors that influence its ability to survive and multiply
within the host. The observation that the crp mutation in both
classical and El Tor strains decreased their virulence in the
infant mouse model is perhaps not surprising, considering the
fact that the crpmutants grew slower in vitro than the wild-type
strains. In S. typhimurium, cya and crp mutants show 10-fold
derepression of the plasmid-borne spv virulence operon rela-
tive to wild-type strains upon entry into stationary phase, yet
they are avirulent (11, 12). Although the molecular mecha-
nisms responsible for these phenotypes are not yet understood,
the lower growth rate of the mutant strains may be a contrib-
uting factor. Because of their avirulence, S. typhimurium cya
and crp mutants have proven to be useful for the preparation
of live oral vaccine derivatives and for the development of
heterologous antigen-delivery systems (43). We are currently
investigating whether V. cholerae crp mutants may have a
similar utility for vaccine development. Live oral vaccine
strains containing a crpmutation should colonize the intestine
less avidly than the current strains and may produce fewer
reactinogenic symptoms (44).
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